IDH Status Predicts Benefit From PCV With Radiation Therapy in Anaplastic Oligodendroglioma (RTOG 9402) Conference

Cairncross, G, Wang, M, Jenkins, R et al. (2012). IDH Status Predicts Benefit From PCV With Radiation Therapy in Anaplastic Oligodendroglioma (RTOG 9402) . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(3), S5-S5. 10.1016/j.ijrobp.2012.07.018

Open Access International Collaboration

cited authors

  • Cairncross, G; Wang, M; Jenkins, R; Shaw, E; Giannini, C; Brachman, D; Buckner, J; Fink, K; Mehta, M; Curran, W

sustainable development goals

authors

date/time interval

  • October 28, 2012 -

publication date

  • November 1, 2012

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • Boston, MA

Digital Object Identifier (DOI)

Conference

  • 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S5

end page

  • S5

volume

  • 84

issue

  • 3